Evidence map›Paper›PMID 40321288›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Cortical differences across psychiatric disorders and associated common and rare genetic variants.

Kuldeep Kumar, Zhijie Liao, Jakub Kopal, Clara Moreau, Christopher R K Ching, Claudia Modenato, Will Snyder, Sayeh Kazem, Charles-Olivier Martin, Anne-Marie Bélanger and 27 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Kuldeep KumarCentre de recherche CHU Sainte-Justine and University of Montreal, Canada.ORCID 0000-0003-3313-135X
Zhijie LiaoCentre de recherche CHU Sainte-Justine and University of Montreal, Canada.
Jakub KopalCentre for Precision Psychiatry, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.ORCID 0000-0002-1201-2872
Clara MoreauCentre de recherche CHU Sainte-Justine and University of Montreal, Canada.ORCID 0000-0001-6217-731X
Christopher R K ChingImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, California, USA.
Claudia ModenatoLREN - Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland.
Will SnyderSection on Developmental Neurogenomics, Human Genetics Branch, NIMH, NIH, Bethesda, MD, USA.
Sayeh KazemCentre de recherche CHU Sainte-Justine and University of Montreal, Canada.
Charles-Olivier MartinCentre de recherche CHU Sainte-Justine and University of Montreal, Canada.
Anne-Marie BélangerCentre de recherche CHU Sainte-Justine and University of Montreal, Canada.
Valérie K FontaineCentre de recherche CHU Sainte-Justine and University of Montreal, Canada.
Khadije JiziCentre de recherche CHU Sainte-Justine and University of Montreal, Canada.
Rune BoenSemel Institute for Neuroscience and Human Behavior, Departments of Psychiatry and Biobehavioral Sciences and Psychology, UCLA, Los Angeles, USA.
Guillaume HuguetCentre de recherche CHU Sainte-Justine and University of Montreal, Canada.
Zohra SaciCentre de recherche CHU Sainte-Justine and University of Montreal, Canada.
Leila KushanSemel Institute for Neuroscience and Human Behavior, Departments of Psychiatry and Biobehavioral Sciences and Psychology, UCLA, Los Angeles, USA.
Ana I SilvaCentre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom.
16p11.2 European Consortium
Simons Searchlight Consortium
Marianne B M van den BreeCentre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom.
David E J LindenCentre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom.
Michael J OwenCentre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom.
Jeremy HallCentre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom.
Sarah LippéCentre de recherche CHU Sainte-Justine and University of Montreal, Canada.
Guillaume DumasCentre de recherche CHU Sainte-Justine and University of Montreal, Canada.
Bogdan DraganskiLREN - Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland.
Laura AlmasyDepartment of Biomedical and Health Informatics, Children's Hospital of Philadelphia, PA, USA.
Sophia I ThomopoulosImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, California, USA.
Neda JahanshadImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, California, USA.
Ida E SønderbyCentre for Precision Psychiatry, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Ole A AndreassenCentre for Precision Psychiatry, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
David C GlahnHarvard Medical School, Department of Psychiatry, 25 Shattuck St, Boston, MA, USA.
Armin RaznahanSection on Developmental Neurogenomics, Human Genetics Branch, NIMH, NIH, Bethesda, MD, USA.
Carrie E BeardenSemel Institute for Neuroscience and Human Behavior, Departments of Psychiatry and Biobehavioral Sciences and Psychology, UCLA, Los Angeles, USA.
Tomas PausCentre de recherche CHU Sainte-Justine and University of Montreal, Canada.
Paul M ThompsonImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, California, USA.
Sébastien JacquemontCentre de recherche CHU Sainte-Justine and University of Montreal, Canada.

Funding

Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
Neurodevelopment and Psychosis in the 22q11.2 Deletion SyndromeR01MH085953 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BEARDEN, CARRIE E · 2010 to 2020
$6.2M
Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive AbilityU01MH119690 · NIMH · BOSTON CHILDREN'S HOSPITAL · PI ALMASY, LAURA A., GLAHN, DAVID C · 2019 to 2023
$5.9M
ENIGMA-COINSTAC-APOE2 Functional and structural connectome protective mechanisms for Alzheimer’s disease and mood disorders: Request for supplemental funds for NIH R01:1R01MH121246R01MH121246 · NIMH · OHIO STATE UNIVERSITY · PI CALHOUN, VINCE D, TURNER, JESS · 2019 to 2023
$5.0M
Integrative Molecular and Phenotype Analysis of 22q11.2 Deletion SyndromeR01MH100900 · NIMH · STANFORD UNIVERSITY · PI HALLMAYER, JOACHIM F · 2013 to 2017
$4.8M
Neurodevelopment and Psychosis in the 22q11.2 Copy Number VariantsR37MH085953 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CARRIE E BEARDEN · 2023 to 2026
$2.9M
ENIGMA-SD: Understanding Sex Differences in Global Mental Health through ENIGMAR01MH116147 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2018 to 2021
$2.5M
Understanding Rare Genetic Variation and Disease Risk: A Global Neurogenetics InitiativeR01MH129858 · NIMH · SAINTE-JUSTINE UNIVERSITY HOSPITAL CTR · PI CARRIE E BEARDEN, Sebastien Jacquemont · 2023 to 2026
$2.4M
Redefine Trans-Neuropsychiatric Disorder Brain Patterns through Big-Data and Machine LearningRF1MH123163 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI KOCHUNOV, PETER V., THOMPSON, PAUL M · 2021 to 2021
$1.2M
Integration of Five Large-Scale Neuropsychiatric Genetic Datasets under the RDoC FrameworkR03MH105808 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BEARDEN, CARRIE E, FEARS, SCOTT C. · 2015 to 2016
$154k
NIBIB NIH HHS U54 EB020403NIMH NIH HHS R01 MH085953NIMH NIH HHS R01 MH100900NIMH NIH HHS R01 MH116147NIMH NIH HHS R01 MH121246NIMH NIH HHS R01 MH129858NIMH NIH HHS R03 MH105808NIMH NIH HHS R37 MH085953NIMH NIH HHS RF1 MH123163NIMH NIH HHS U01 MH119690Wellcome Trust
6 · The paper itself

Abstract

Genetic studies have identified common and rare variants increasing the risk for neurodevelopmental and psychiatric disorders (NPDs). These risk variants have also been shown to influence the structure of the cerebral cortex. However, it is unknown whether cortical differences associated with genetic variants are linked to the risk they confer for NPDs. To answer this question, we analyzed cortical thickness (CT) and surface area (SA) for common and rare variants associated with NPDs, in ~33000 individuals from the general population and clinical cohorts, as well as ENIGMA summary statistics for 8 NPDs. Rare and common genetic variants increasing risk for NPDs were preferentially associated with total SA, while NPDs were preferentially associated with mean CT. Larger effects on mean CT, but not total SA, were observed in NPD medicated subgroups. At the regional level, genetic variants were preferentially associated with effects in sensorimotor areas, while NPDs showed higher effects in association areas. We show that schizophrenia- and bipolar-disorder-associated SNPs show positive and negative effect sizes on SA suggesting that their aggregated effects cancel out in additive polygenic models. Overall, CT and SA differences associated with NPDs do not relate to those observed across individual genetic variants and may be linked with critical non-genetic factors, such as medication and the lived experience of the disorder.

Identifiers

PMID40321288
PMCPMC12047953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.